ArticleTherapeutic advances in medical oncology2023

Cost-effectiveness analysis of serplulimab in combination with cisplatin plus 5-fluorouracil chemotherapy compared to cisplatin plus 5-fluorouracil chemotherapy as first-line treatment for advanced or metastatic esophageal squamous cell carcinoma in China.

Ying-Tao Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.